Correlation of STAT1 expression with better prognosis has been reported for several cancers, including colorectal cancer [26–29], esophageal cancer [30], pancreatic cancer [31], hepatocellular carcinoma [32], soft tissue sarcoma [33], and metastatic melanomas [34]. This evidence concerns the gene STAT1 and pancreatic neoplasm.